Jiangsu Recbio Technology Revenue

In the year 2025, Jiangsu Recbio Technology had annual revenue of 12.73M CNY, down -52.88%. Jiangsu Recbio Technology had revenue of -7.00M in the half year ending December 31, 2025, a decrease of -127.16%.

Revenue

12.73M CNY

Revenue Growth

-52.88%

P/S Ratio

220.82

Revenue / Employee

25.92K CNY

Employees

491

Market Cap

3.13B HKD

Revenue Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	12.73M	-14.28M	-52.88%
Dec 31, 2024	27.01M	-3.37M	-11.10%
Dec 31, 2023	30.38M	25.05M	470.46%
Dec 31, 2022	5.33M	-874.00K	-14.10%
Dec 31, 2021	6.20M	4.74M	325.17%
Dec 31, 2020	Pro	Pro	Pro
Dec 31, 2019	Pro	Pro	Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name	Revenue
AIM Vaccine	1.30B
Medtide	634.40M
Antengene Corporation	117.22M
BioDlink International Company	831.99M
Viva Biotech Holdings	1.92B
Mirxes Holding Company	166.32M
Clover Biopharmaceuticals	3.90M
TYK Medicines	117.25K

Revenue Rankings